https://www.turkmenistanhealthnews.com/article/915713426-medicenna-announces-closing-of-public-offering-of-units-raising-cdn-4-44-million-to-support-lead-programs Turkmenistan Health News en PressRelease 2026-05-28T13:10:38+00:00 Medicenna Announces Closing of Public Offering of Units Raising CDN$4.44 Million to Support Lead Programs https://ml.globenewswire.com/media/7e312e67-9924-4773-b548-47ed05d54904/small/new-logo-small-png.png https://www.turkmenistanhealthnews.com/article/915713385-mink-therapeutics-announces-first-patient-dosed-in-randomized-phase-2-trial-of-agent-797-in-acute-lung-injury-and-critical-illness Turkmenistan Health News en PressRelease 2026-05-28T13:04:49+00:00 MiNK Therapeutics Announces First Patient Dosed in Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness https://ml.globenewswire.com/media/6aa8e960-515a-40d6-9894-39ca47f5c84e/small/mink-logo-loyal-blue-and-light-blue-png.png https://www.turkmenistanhealthnews.com/article/915711575-new-progyny-study-shows-growing-demand-for-human-guidance-in-an-increasingly-digital-healthcare-system Turkmenistan Health News en PressRelease 2026-05-28T13:04:00+00:00 New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System https://ml.globenewswire.com/media/1342dacd-99c3-4043-af8a-2fd5e9ea569f/small/progyny-203860-no-tag-png.png https://www.turkmenistanhealthnews.com/article/915711255-disney-and-philips-bring-together-beloved-storytelling-and-innovative-technology-to-support-kids-undergoing-mri-exams Turkmenistan Health News en PressRelease 2026-05-28T13:00:00+00:00 Disney and Philips bring together beloved storytelling and innovative technology to support kids undergoing MRI exams https://ml-eu.globenewswire.com/media/e5826782-01bc-45e7-b448-9ca1eae0125e/small/philips-logo-logotype-emblem-700x128-png.png https://www.turkmenistanhealthnews.com/article/915712345-teladoc-health-expands-access-to-care-through-walmart-s-better-care-services Turkmenistan Health News en PressRelease 2026-05-28T13:00:00+00:00 Teladoc Health Expands Access to Care Through Walmart’s Better Care Services https://ml.globenewswire.com/media/35d65dec-a7ff-43ac-89c0-86e66c3bf150/medium/teladoc-health.jpg https://www.turkmenistanhealthnews.com/article/915712566-ataibeckley-launches-patient-impact-grant-program-for-mental-health-non-profit-organizations Turkmenistan Health News en PressRelease 2026-05-28T13:00:00+00:00 AtaiBeckley Launches Patient Impact Grant Program for Mental Health Non-Profit Organizations https://ml.globenewswire.com/media/cea08bf4-0562-45ed-af5c-c9376c48a6eb/small/ataibeckley-horizontal-2color-png.png https://www.turkmenistanhealthnews.com/article/915713014-syneos-health-appoints-greg-licholai-as-chief-medical-officer-to-advance-next-generation-drug-development Turkmenistan Health News en PressRelease 2026-05-28T13:00:00+00:00 Syneos Health Appoints Greg Licholai as Chief Medical Officer to Advance Next-Generation Drug Development https://ml.globenewswire.com/media/6b3b2435-841a-44d4-becd-d8625ca90975/small/syneos-health-rgb-r-jpg.jpg https://www.turkmenistanhealthnews.com/article/915713351-global-alzheimer-s-platform-foundation-announces-strategic-collaboration-and-partnership-with-circular-genomics-for-the-transformative-bio-hermes-001 Turkmenistan Health News en PressRelease 2026-05-28T13:00:00+00:00 Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Circular Genomics for the Transformative Bio-Hermes-001 Study https://ml.globenewswire.com/media/79913531-32c1-476a-8d22-887b6775a191/small/gap-logo-1708444397196-png.png https://www.turkmenistanhealthnews.com/article/915711544-just-salad-opens-in-ardmore-pa Turkmenistan Health News en PressRelease 2026-05-28T12:57:00+00:00 Just Salad Opens in Ardmore, Pa. https://ml.globenewswire.com/media/c9ab0d11-72af-476b-bd04-f99ec41a2667/medium/just-salad-ardmore-pennsylvania-storefront-exterior.jpg https://www.turkmenistanhealthnews.com/article/915712720-entera-s-eb613-first-in-class-oral-pth-1-34-anabolic-for-osteoporosis-single-tablet-data-selected-for-late-breaking-oral-presentation-at-endo-2026 Turkmenistan Health News en PressRelease 2026-05-28T12:50:00+00:00 Entera’s EB613, First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis - Single Tablet Data Selected for Late Breaking Oral Presentation at ENDO 2026 Annual Meeting; Additional Oral Peptide Pipeline Data Accepted for Presentation https://ml.globenewswire.com/media/cad5c2b9-1536-4364-aa1b-6b8216d3658f/small/logo-color-ribua-png.png https://www.turkmenistanhealthnews.com/article/915713207-scisparc-subsidiary-neurothera-labs-received-conditional-regulatory-approval-for-acquisition-of-cliniquantum Turkmenistan Health News en PressRelease 2026-05-28T12:40:00+00:00 SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum https://ml.globenewswire.com/media/bcad2b2c-74a6-4d74-b0f3-6f42a3c00a90/small/scilogo-jpg.jpg https://www.turkmenistanhealthnews.com/article/915712557-foxo-technologies-inc-forms-strategic-partnership-with-longevityfp-technologies-llc-to-commercialize-foxo-s-epigenetics-technology Turkmenistan Health News en PressRelease 2026-05-28T12:33:00+00:00 FOXO TECHNOLOGIES, INC., FORMS STRATEGIC PARTNERSHIP WITH LONGEVITYFP TECHNOLOGIES, LLC. TO COMMERCIALIZE FOXO’S EPIGENETICS TECHNOLOGY https://ml.globenewswire.com/media/99dbae4d-1246-4df7-b93c-275736927771/small/logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/915711515-lexicon-pharmaceuticals-to-present-at-the-2026-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-28T12:30:00+00:00 Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/afcf3b59-ca71-40ed-9226-a0901bf4d13b/small/logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/915712066-celcuity-to-participate-in-upcoming-investor-conferences Turkmenistan Health News en PressRelease 2026-05-28T12:30:00+00:00 Celcuity To Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/dab74495-313f-47dd-a6cb-b42a7f024edd/small/celcuity-logo-rgb-jpg.jpg https://www.turkmenistanhealthnews.com/article/915712071-vor-bio-to-participate-in-the-2026-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-28T12:30:00+00:00 Vor Bio to Participate in the 2026 Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/dde67700-b1b4-40c4-b930-13bd71804762/small/vor-wordmark-rgb-fullcolor-070920-png.png https://www.turkmenistanhealthnews.com/article/915712338-newgen-executes-share-purchase-agreement-and-obtains-exclusive-apac-agency-rights-with-k25-ai-an-ai-powered-prediction-market-led-by-industry-veteran Turkmenistan Health News en PressRelease 2026-05-28T12:30:00+00:00 NewGen Executes Share Purchase Agreement and Obtains Exclusive APAC Agency Rights with K25.ai, an AI-Powered Prediction Market Led by Industry Veteran Andy Cheung https://ml.globenewswire.com/media/YjM1YTk3YWUtNDI0Ny00NDMyLWFjOWQtOTgxYzllYjJhYWJmLTEyOTcwMTEtMjAyNi0wNS0yOC1lbg==/tiny/NewGenIvf-Limited.png https://www.turkmenistanhealthnews.com/article/915712401-vivani-medical-ceo-adam-mendelsohn-to-present-at-the-jefferies-global-healthcare-conference-on-june-4-2026 Turkmenistan Health News en PressRelease 2026-05-28T12:30:00+00:00 Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026 https://ml.globenewswire.com/media/c63d8439-dc26-4ef7-af2c-4ec0db8feb4b/small/vivani-medical-600-jpg.jpg https://www.turkmenistanhealthnews.com/article/915712548-sapu-nano-unveils-progress-in-deciparticle-nanomedicine-platform-and-ai-driven-oncology-development-at-bio-2026 Turkmenistan Health News en PressRelease 2026-05-28T12:30:00+00:00 Sapu Nano Unveils Progress in Deciparticle™ Nanomedicine Platform and AI-Driven Oncology Development at BIO 2026 https://ml.globenewswire.com/media/aa650511-a1c3-496e-803a-448d7f8d409a/small/picture1-jpg.jpg https://www.turkmenistanhealthnews.com/article/915712728-polaryx-therapeutics-announces-closing-of-10-million-private-placement-equity-financing-to-support-launch-of-soteria-phase-2-basket-trial Turkmenistan Health News en PressRelease 2026-05-28T12:30:00+00:00 Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial https://ml.globenewswire.com/media/64e2f507-40e8-46aa-b22e-6661e7035467/small/polaryx-logonew-png.png https://www.turkmenistanhealthnews.com/article/915712876-renovorx-announces-fda-orphan-drug-designation-granted-oxaliplatin-for-the-treatment-of-pancreatic-cancer Turkmenistan Health News en PressRelease 2026-05-28T12:30:00+00:00 RenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreatic Cancer https://ml.globenewswire.com/media/e18bf823-ff44-4bbd-82b9-3a311d58dad8/small/final-logo-horizontal-png.png https://www.turkmenistanhealthnews.com/article/915713050-aclaris-therapeutics-to-participate-in-the-2026-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-28T12:30:00+00:00 Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/de2bcb21-de59-4226-bc8b-b1b747461f51/small/aclaris-logo-clr-jpg.jpg https://www.turkmenistanhealthnews.com/article/915712243-10x-health-launches-new-supplements-to-address-mobility-circulation Turkmenistan Health News en PressRelease 2026-05-28T12:29:00+00:00 10X Health Launches New Supplements to Address Mobility & Circulation https://ml.globenewswire.com/media/904e6bc5-47b8-4b48-b9d5-0873f2211de0/small/logos-10xhealth-dual-01-jpg.jpg https://www.turkmenistanhealthnews.com/article/915712503-biomerica-lands-a-1-75-million-cdmo-master-services-agreement-for-ivd-diagnostic-development Turkmenistan Health News en PressRelease 2026-05-28T12:19:00+00:00 Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development https://ml.globenewswire.com/media/3461b9f0-3e95-484f-96e9-71608fc20239/small/biomerica-png.png https://www.turkmenistanhealthnews.com/article/915711814-verrica-pharmaceuticals-to-participate-in-the-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-28T12:05:00+00:00 Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/4938c2eb-43f1-4f6c-a1e1-82ab7fb66c3b/small/verrica-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/915711405-newamsterdam-pharma-to-participate-at-upcoming-investor-conferences-in-june Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June https://ml.globenewswire.com/media/f7b8b881-9461-4712-9965-707ed3bdd573/small/newamsterdam-logo-full-color-final-png.png https://www.turkmenistanhealthnews.com/article/915711501-bionano-announces-full-retirement-of-outstanding-senior-secured-convertible-debentures Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures https://ml.globenewswire.com/media/5ba4072e-6e59-46e7-847c-6aaf7755bbbf/small/bionano-rgb-png.png https://www.turkmenistanhealthnews.com/article/915711509-akebia-therapeutics-to-present-at-the-2026-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 Akebia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/c7f3708e-3328-4668-95c6-e7646efd653a/small/akebia-logo-fullcolor-rgb-png.png https://www.turkmenistanhealthnews.com/article/915711518-jushi-holdings-inc-announces-applications-submitted-for-dea-registration-of-state-licensed-medical-cannabis-operations Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 Jushi Holdings Inc. Announces Applications Submitted for DEA Registration of State-Licensed Medical Cannabis Operations https://ml.globenewswire.com/media/e65f15fd-322c-4847-83c5-ceafe27f97d5/small/jushi-png.png https://www.turkmenistanhealthnews.com/article/915711557-artiva-biotherapeutics-to-participate-in-the-2026-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 Artiva Biotherapeutics to Participate in the 2026 Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/0392544b-ecff-4590-9eed-59c934e1ba4d/small/artiva-biotherapeutics-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/915711579-prime-medicine-to-present-at-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 Prime Medicine to Present at Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/ebddcf3b-2b71-4df6-99e8-d07617d9e327/small/prime-medicine-logo-approved-color-png.png https://www.turkmenistanhealthnews.com/article/915711705-medicus-pharma-announces-22-million-non-dilutive-financing Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 Medicus Pharma Announces $22 Million Non-Dilutive Financing https://ml.globenewswire.com/media/0f5af1d1-dfba-4810-baac-d1922c0558c1/small/medicus-logo-rgb-05-aspect-1500px-globe-newswire-2-jpg.jpg https://www.turkmenistanhealthnews.com/article/915711881-metagenomi-therapeutics-inc-to-present-at-the-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/7680f6bf-0803-4567-93bd-b52fc13a7887/small/new-mgx-logo-png.png https://www.turkmenistanhealthnews.com/article/915711916-design-therapeutics-to-participate-in-2026-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 Design Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/bbfe687d-5236-42ea-8012-8ab435c6914d/small/designtx-logo-colored-png.png https://www.turkmenistanhealthnews.com/article/915711923-world-trade-center-health-program-launches-national-awareness-initiative-to-reach-those-who-were-impacted-by-9-11-as-children-or-teens Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 World Trade Center Health Program Launches National Awareness Initiative to Reach Those Who Were Impacted by 9/11 as Children or Teens https://ml.globenewswire.com/media/9bd799fb-2c06-4aed-adf9-8c25e0d309be/small/wtchp-4-color-horizontal-png.png https://www.turkmenistanhealthnews.com/article/915711957-aveanna-healthcare-announces-successful-debt-repricing Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 Aveanna Healthcare Announces Successful Debt Repricing https://ml.globenewswire.com/media/d3896f9e-a6a1-48c1-a8f7-d9ba5d7433d6/small/aveanna-healthcare-500x262-png.png https://www.turkmenistanhealthnews.com/article/915711964-biocardia-announces-japan-pmda-record-of-advice-supports-regulatory-submission-for-approval-of-cardiamp-cell-therapy-for-ischemic-heart-failure Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 BioCardia Announces Japan PMDA Record Of Advice Supports Regulatory Submission For Approval Of CardiAMP Cell Therapy For Ischemic Heart Failure https://ml.globenewswire.com/media/4641bb53-4913-4654-a337-79383a5c7ab9/small/biocardia-final-logo-2016-jpeg-jpg.jpg https://www.turkmenistanhealthnews.com/article/915712099-procept-biorobotics-advances-prostate-cancer-program-with-water-iv-study-enrollment-completion-and-expanded-ide-approval Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval https://ml.globenewswire.com/media/4f4bd11e-cbd0-4365-8b2c-b55a77eb8bdd/medium/figure-aquablation-therapy-for-prostate-cancer.png https://www.turkmenistanhealthnews.com/article/915712156-systemic-immune-activation-with-eftilagimod-alfa-associated-with-statistically-significant-increased-overall-survival-in-late-stage-cancer-patients Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 Systemic immune activation with eftilagimod alfa associated with statistically significant increased overall survival in late-stage cancer patients https://ml.globenewswire.com/media/b2cd55d0-59ab-45ac-a1fe-5cf2adac7f24/small/immutep-new-logo-png.png https://www.turkmenistanhealthnews.com/article/915712170-cogent-biosciences-announces-fda-acceptance-of-new-drug-application-nda-with-priority-review-for-bezuclastinib-in-combination-with-sunitinib-for Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) with Priority Review for Bezuclastinib in Combination with Sunitinib for Patients with GIST https://ml.globenewswire.com/media/2b8cbfab-a4de-4e17-bdd6-7ef597a95d2e/small/cogent-biosciences-logo-rgb-png.png https://www.turkmenistanhealthnews.com/article/915712298-eupraxia-pharmaceuticals-to-participate-in-the-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 Eupraxia Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/0b2bbe4b-1cf9-402e-8ea6-22c0043f310a/small/eupraxia-color-med-res-01-jpg.jpg https://www.turkmenistanhealthnews.com/article/915712307-crispr-therapeutics-to-participate-in-upcoming-investor-conferences Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 CRISPR Therapeutics to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/5dac7d0d-131d-4047-bab7-db8e0719bf58/small/crispr-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/915712319-conavi-medical-reports-fiscal-second-quarter-2026-results-and-operational-highlights Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 Conavi Medical Reports Fiscal Second Quarter 2026 Results and Operational Highlights https://ml.globenewswire.com/media/4a28f1c0-f99d-4940-b2a7-201ab98cdaff/small/conavi-jpg.jpg https://www.turkmenistanhealthnews.com/article/915712469-thousands-of-people-march-to-protest-ford-s-hospital-privatization-demand-he-return-that-funding-to-our-public-hospitals Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 Thousands of people march to protest Ford’s hospital privatization, Demand he return that funding to our public hospitals https://ml.globenewswire.com/media/fdd00e9f-f066-4244-85e8-d12e6d1b760c/small/screen-shot-2023-09-14-at-1-49-15-pm-png.png https://www.turkmenistanhealthnews.com/article/915712522-rhythm-pharmaceuticals-announces-publication-of-new-bardet-biedl-syndrome-diagnostic-algorithm-in-the-american-journal-of-medical-genetics Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 Rhythm Pharmaceuticals Announces Publication of New Bardet-Biedl Syndrome Diagnostic Algorithm in the American Journal of Medical Genetics https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg https://www.turkmenistanhealthnews.com/article/915712630-actinogen-receives-positive-ema-scientific-advice-aligned-with-prior-fda-guidance-for-its-alzheimer-s-disease-program Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 Actinogen receives positive EMA scientific advice aligned with prior FDA guidance for its Alzheimer’s disease program https://ml.globenewswire.com/media/e5165e23-ec4b-45f4-b198-93ce4f78d1c2/small/actinogen-logo-colour-750x750px-png.png https://www.turkmenistanhealthnews.com/article/915712699-medipharm-labs-reminds-shareholders-of-upcoming-annual-and-special-meeting Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 MediPharm Labs Reminds Shareholders of Upcoming Annual and Special Meeting https://ml.globenewswire.com/media/7a534238-60aa-4187-979d-8f4d83fa58c1/small/medipharm-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/915712767-sol-gel-reports-first-quarter-2026-financial-results-and-provides-corporate-updates Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 Sol-Gel Reports First Quarter 2026 Financial Results and Provides Corporate Updates https://ml.globenewswire.com/media/bed42597-8dee-4c05-a87a-719a92370c46/small/sol-gel-new-logo-light-jpg.jpg https://www.turkmenistanhealthnews.com/article/915712855-enlivex-treasury-portfolio-update-rain-holdings-valued-at-approximately-1-16-billion-rain-foundation-appoints-industry-leaders-to-advisory-board Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.16 Billion; Rain Foundation Appoints Industry Leaders to Advisory Board https://ml.globenewswire.com/media/27d4e006-8709-4fd1-8341-5b58381487d4/small/picture1-jpg.jpg https://www.turkmenistanhealthnews.com/article/915712888-oruka-therapeutics-to-present-at-the-2026-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-28T12:00:00+00:00 Oruka Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/3950d2d7-850d-459a-9e42-07c642a841c5/small/oruka-full-color-jpg.jpg https://www.turkmenistanhealthnews.com/article/915696124-tg-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-28T11:30:00+00:00 TG Therapeutics to Participate in the Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/0e613f5f-8c22-4c63-a73b-c08cc0fbec64/small/tgtx-2021-logo.jpg https://www.turkmenistanhealthnews.com/article/915696154-compass-therapeutics-to-participate-in-upcoming-june-investor-events Turkmenistan Health News en PressRelease 2026-05-28T11:30:00+00:00 Compass Therapeutics to Participate in Upcoming June Investor Events https://ml.globenewswire.com/media/b8470129-5d30-4368-8074-d77404b65be8/small/compass-logo-rgb-outlines-png.png https://www.turkmenistanhealthnews.com/article/915696565-dyadic-and-scripps-research-collaborate-on-rapid-response-hantavirus-antibody-and-vaccine-development Turkmenistan Health News en PressRelease 2026-05-28T11:25:00+00:00 Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development https://ml.globenewswire.com/media/c67f7901-660b-41c0-a160-0f92fd04bb42/small/dyadic-applied-biosolutions-jpg.jpg https://www.turkmenistanhealthnews.com/article/915696314-aurora-spine-corporation-announces-first-quarter-fy26-financial-results Turkmenistan Health News en PressRelease 2026-05-28T11:15:00+00:00 Aurora Spine Corporation Announces First Quarter FY26 Financial Results https://ml.globenewswire.com/media/af1a0a7b-b883-41f9-8c86-a89bad3cc4a4/small/aurora12-jpg.JPG https://www.turkmenistanhealthnews.com/article/915696578-zenas-biopharma-announces-submission-of-biologics-license-application-bla-to-u-s-fda-for-obexelimab-in-igg4-rd Turkmenistan Health News en PressRelease 2026-05-28T11:05:00+00:00 Zenas BioPharma Announces Submission of Biologics License Application (BLA) to U.S. FDA for Obexelimab in IgG4-RD https://ml.globenewswire.com/media/11a7c081-eaf9-4e1d-b413-227c20d8d41a/small/zenas-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/915696138-novabridge-to-present-at-the-2026-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-28T11:00:00+00:00 NovaBridge to Present at the 2026 Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/0ea9f005-c7f7-4272-a3ac-cbf4ea4aef15/small/novabridge-logo-en-rgb-png.png https://www.turkmenistanhealthnews.com/article/915696152-premium-craft-cannabis-brand-broken-coast-launches-cherry-ztripez-flower-and-pre-rolls-for-summer Turkmenistan Health News en PressRelease 2026-05-28T11:00:00+00:00 Premium Craft Cannabis Brand Broken Coast Launches Cherry Ztripez Flower and Pre-Rolls for Summer https://ml.globenewswire.com/media/3990d913-0873-413f-b4f4-f911b20f57fd/medium/bcc-packaging-image.png https://www.turkmenistanhealthnews.com/article/915696204-treos-bio-appoints-sunjeet-sawhney-as-chief-executive-officer Turkmenistan Health News en PressRelease 2026-05-28T11:00:00+00:00 TREOS Bio Appoints Sunjeet Sawhney as Chief Executive Officer https://ml.globenewswire.com/media/dd2e60c2-b90a-4ba3-b034-6d3dc0267581/small/treos-logo-png.png https://www.turkmenistanhealthnews.com/article/915696330-relmada-therapeutics-to-present-at-the-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-28T11:00:00+00:00 Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/8a986b0a-11c8-4551-b0ad-ec20fe2fe40a/small/relmada-logo-png.png https://www.turkmenistanhealthnews.com/article/915696337-bioxcel-therapeutics-presents-new-data-from-serenity-at-home-phase-3-trial-for-agitation-associated-with-bipolar-disorders-or-schizophrenia-at-2026 Turkmenistan Health News en PressRelease 2026-05-28T11:00:00+00:00 BioXcel Therapeutics Presents New Data from SERENITY At-Home Phase 3 Trial for Agitation Associated with Bipolar Disorders or Schizophrenia at 2026 ASCP Annual Meeting https://ml.globenewswire.com/media/63fea215-2cfc-4e2b-b169-43dcfff60b34/small/btai-logo-png-220x123-png.png https://www.turkmenistanhealthnews.com/article/915696342-bpgbio-to-present-ongoing-phase-2-study-trial-in-progress-update-of-bpm31510-in-newly-diagnosed-glioblastoma-at-asco-2026 Turkmenistan Health News en PressRelease 2026-05-28T11:00:00+00:00 BPGbio to Present Ongoing Phase 2 Study Trial-in-Progress Update of BPM31510 in Newly Diagnosed Glioblastoma at ASCO 2026 https://ml.globenewswire.com/media/03ad3a91-4c18-4916-94a1-289e3fa11fa3/medium/bpgbio-to-present-ongoing-phase-2-study-trial-in-progress-up.png https://www.turkmenistanhealthnews.com/article/915696411-nrx-pharmaceuticals-nasdaq-nrxp-strategic-partner-emobot-presents-late-breaking-clinical-validation-of-the-emocare-depression-thermometer-at-ascp Turkmenistan Health News en PressRelease 2026-05-28T11:00:00+00:00 NRx Pharmaceuticals (Nasdaq: NRXP) Strategic Partner Emobot Presents Late-Breaking Clinical Validation of the EMOCARE Depression Thermometer at ASCP 2026 https://ml.globenewswire.com/media/d879f1ff-d5d7-48d7-9731-c881b469d873/small/nrx-logo-300dpi-png.png https://www.turkmenistanhealthnews.com/article/915696540-tiziana-life-sciences-to-present-at-the-jefferies-global-healthcare-conference-in-new-york Turkmenistan Health News en PressRelease 2026-05-28T11:00:00+00:00 Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York https://ml.globenewswire.com/media/991c340c-a083-4bcb-ad41-e7eea83f6f97/small/tiziana-logo-png.png https://www.turkmenistanhealthnews.com/article/915696316-felix-offers-ozempic-at-generic-level-pricing-as-lower-cost-glp-1-demand-remains-elevated-across-canada Turkmenistan Health News en PressRelease 2026-05-28T10:58:00+00:00 Felix Offers Ozempic at Generic-Level Pricing as Lower-Cost GLP-1 Demand Remains Elevated Across Canada https://ml.globenewswire.com/media/34f01f28-be97-40ad-8a49-b70850fe9f7d/small/felix-health-orange-logo-png.png https://www.turkmenistanhealthnews.com/article/915681509-world-bicycle-day-experience-denmark-through-danish-wheelness Turkmenistan Health News en PressRelease 2026-05-28T10:29:42+00:00 World Bicycle Day: Experience Denmark through Danish Wheelness™ https://ml.globenewswire.com/media/MjRhOTNhZTMtNDExMi00NmI3LWJkZTMtMTJhN2YyMjg4YzY4LTUwMDE1NTU4My0yMDI2LTA1LTI4LWVu/tiny/VISITDENMARK.png https://www.turkmenistanhealthnews.com/article/915681429-radnet-to-host-men-s-health-webinar-on-june-13-2026 Turkmenistan Health News en PressRelease 2026-05-28T10:00:00+00:00 RadNet to Host Men's Health Webinar on June 13, 2026 https://ml.globenewswire.com/media/0df5f357-aa64-4998-a83f-f1561aef685d/small/logo-radnet-profile2-jpg.jpg https://www.turkmenistanhealthnews.com/article/915681484-innocare-announces-the-acceptance-of-new-drug-application-for-orelabrutinib-in-primary-immune-thrombocytopenia-in-china Turkmenistan Health News en PressRelease 2026-05-28T09:22:10+00:00 InnoCare Announces the Acceptance of New Drug Application for Orelabrutinib in Primary Immune Thrombocytopenia in China https://ml.globenewswire.com/media/2dc70b00-a0b0-4d85-adef-2717a7067aec/small/innocare-eng-logo-horizontal-png.png https://www.turkmenistanhealthnews.com/article/915668855-xl-protein-launches-spin-off-pasylanta-therapeutics-to-develop-long-acting-il-1ra-biobetters Turkmenistan Health News en PressRelease 2026-05-28T08:00:00+00:00 XL‑protein Launches Spin-Off PASylANTA Therapeutics to Develop Long‑Acting IL‑1Ra Biobetters https://pressranger.s3.us-west-1.amazonaws.com/3324332/PASylANTA-Logo-150-DPI.png https://www.turkmenistanhealthnews.com/article/915668861-anaveon-reports-clinical-benefit-of-anv600-in-the-expand-1-phase-1-clinical-trial-at-asco-2026-and-actively-seeks-partners-for-its-legacy-oncology Turkmenistan Health News en PressRelease 2026-05-28T08:00:00+00:00 Anaveon Reports Clinical Benefit of ANV600 in the EXPAND-1 Phase 1 Clinical Trial at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio https://ml.globenewswire.com/media/376f71da-1a19-4a9a-bb0a-5d12feb63780/small/logo-anaveon-jpg.jpg https://www.turkmenistanhealthnews.com/article/915656749-synklino-announces-first-patient-dosed-in-phase-1-trial-of-syn002-for-cmv-prevention-in-kidney-transplantation Turkmenistan Health News en PressRelease 2026-05-28T07:30:00+00:00 Synklino announces first patient dosed in Phase 1 trial of SYN002 for CMV prevention in kidney transplantation https://ml-eu.globenewswire.com/media/339f86f2-49a0-4d86-ad0d-d6ee8e7e69b2/small/brown-rgb-png.png https://www.turkmenistanhealthnews.com/article/915656755-vicentra-scales-commercial-manufacturing-triples-capacity-and-strengthens-unit-economics Turkmenistan Health News en PressRelease 2026-05-28T07:30:00+00:00 ViCentra Scales Commercial Manufacturing, Triples Capacity and Strengthens Unit Economics https://ml-eu.globenewswire.com/media/97cc2ebe-8f0d-4051-aca4-6350b6043071/small/vicentra-logo-png.png https://www.turkmenistanhealthnews.com/article/915656745-theolytics-ongoing-us-phase-1-octopod-ip-trial-of-theo-260-in-ovarian-cancer-to-be-presented-as-a-trial-in-progress-at-asco-2026 Turkmenistan Health News en PressRelease 2026-05-28T07:00:00+00:00 Theolytics’ Ongoing US Phase 1 OCTOPOD-IP Trial of THEO-260 in Ovarian Cancer to be Presented as a Trial in Progress at ASCO 2026 https://ml-eu.globenewswire.com/media/09792f9d-ea04-4e1e-8cc1-4b0415468690/small/theolytics-jpg.jpg https://www.turkmenistanhealthnews.com/article/915656762-groundbreaking-therapy-for-advanced-heart-failure-outcomes-of-the-biovat-hf-clinical-trial-published-in-nejm Turkmenistan Health News en PressRelease 2026-05-28T07:00:00+00:00 Groundbreaking therapy for advanced heart failure: Outcomes of the BIOVAT-HF clinical trial published in NEJM https://ml-eu.globenewswire.com/media/3d3e4738-405b-4e38-80fc-a33e241c6d40/small/image1-png.png https://www.turkmenistanhealthnews.com/article/915644736-enterome-receives-u-s-fda-orphan-drug-designation-for-eo2463-oncomimics-to-treat-watch-and-wait-indolent-non-hodgkin-lymphoma Turkmenistan Health News en PressRelease 2026-05-28T06:00:00+00:00 Enterome receives U.S. FDA Orphan Drug Designation for EO2463 OncoMimics™ to treat “watch-and-wait” indolent non-Hodgkin lymphoma https://ml-eu.globenewswire.com/media/e04b919f-9b3c-4d80-af54-707d3fa48216/small/enterome-logo-png.png https://www.turkmenistanhealthnews.com/article/915644789-trogenix-doses-first-patient-in-phase-i-ii-clinical-trial-of-tgx-007-gene-therapy-for-glioblastoma Turkmenistan Health News en PressRelease 2026-05-28T06:00:00+00:00 Trogenix doses first patient in Phase I/II clinical trial of TGX-007 gene therapy for glioblastoma https://ml-eu.globenewswire.com/media/1df677d2-fb59-4859-a4a8-d74bdb945eca/small/trogenix-rgb-80-jpg.jpg https://www.turkmenistanhealthnews.com/article/915644821-new-late-breaking-data-reinforces-iqirvo-s-impact-on-alp-fatigue-and-pruritus-in-pbc Turkmenistan Health News en PressRelease 2026-05-28T05:30:00+00:00 New late-breaking data reinforces IQIRVO®’s impact on ALP, fatigue and pruritus in PBC https://ml-eu.globenewswire.com/media/81292fcc-6b3a-4e4a-a083-ea4191bf920a/small/ipsen-notified-website-1200x628pix-500kb-max-jpg.jpg https://www.turkmenistanhealthnews.com/article/915644843-de-nouvelles-donn-es-late-breaking-renforcent-l-impact-d-iqirvo-sur-l-alp-la-fatigue-et-le-prurit-dans-la-cbp Turkmenistan Health News en PressRelease 2026-05-28T05:30:00+00:00 De nouvelles données "late-breaking" renforcent l’impact d’IQIRVO® sur l’ALP, la fatigue et le prurit dans la CBP. https://ml-eu.globenewswire.com/media/81292fcc-6b3a-4e4a-a083-ea4191bf920a/small/ https://www.turkmenistanhealthnews.com/article/915632078-basilea-erh-lt-weitere-usd-13-mio-von-barda-zur-entwicklung-des-neuartigen-antibiotikums-ceftibuten-ledaborbactam Turkmenistan Health News en PressRelease 2026-05-28T05:15:00+00:00 Basilea erhält weitere USD 13 Mio. von BARDA zur Entwicklung des neuartigen Antibiotikums Ceftibuten-Ledaborbactam https://ml-eu.globenewswire.com/media/4403c5ae-6c9a-43d2-8c5f-deb2de747a47/small/basilea-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/915632120-basilea-receives-further-usd-13-million-from-barda-to-continue-development-of-novel-antibiotic-ceftibuten-ledaborbactam Turkmenistan Health News en PressRelease 2026-05-28T05:15:00+00:00 Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam https://ml-eu.globenewswire.com/media/4403c5ae-6c9a-43d2-8c5f-deb2de747a47/small/basilea-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/915632145-veraxa-biotech-strengthens-financial-position-with-27-5-million-principal-amount-senior-secured-note-financing-and-50-million-share-purchase Turkmenistan Health News en PressRelease 2026-05-28T05:11:00+00:00 VERAXA Biotech Strengthens Financial Position with $27.5 Million Principal Amount Senior Secured Note Financing and $50 Million Share Purchase Agreement https://ml-eu.globenewswire.com/media/68c194cf-5640-40eb-b4a2-7263d62271c5/small/veraxa-logo-blue-on-white-png.png https://www.turkmenistanhealthnews.com/article/915632102-press-release-sanofi-s-venglustat-accepted-for-priority-review-in-the-us-to-treat-type-3-gaucher-disease Turkmenistan Health News en PressRelease 2026-05-28T05:00:00+00:00 Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/915632125-communiqu-de-presse-le-venglustat-de-sanofi-a-t-accept-pour-un-examen-prioritaire-aux-tats-unis-afin-de-traiter-la-maladie-de-gaucher-de-type-3 Turkmenistan Health News en PressRelease 2026-05-28T05:00:00+00:00 Communiqué de presse : Le venglustat de Sanofi a été accepté pour un examen prioritaire aux États-Unis afin de traiter la maladie de Gaucher de type 3   https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/915632156-argenx-to-host-myositis-r-d-webinar-on-june-23-2026 Turkmenistan Health News en PressRelease 2026-05-28T05:00:00+00:00 argenx to Host Myositis R&D Webinar on June 23, 2026 https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png https://www.turkmenistanhealthnews.com/article/915568072-memora-supplement-under-investigation-effective-brain-booster-formula-against-emf-radiation-latest-memory-health-report Turkmenistan Health News en PressRelease 2026-05-27T23:07:08+00:00 Memora Supplement Under Investigation: Effective Brain Booster Formula Against EMF Radiation - Latest Memory Health Report https://zingfast.com/wp-content/uploads/2026/05/Memora-Supplement.jpg https://www.turkmenistanhealthnews.com/article/915567991-young-people-do-not-lack-ambition-it-s-the-system-failing-them Turkmenistan Health News en PressRelease 2026-05-27T23:01:00+00:00 Young people do not lack ambition; it’s the system failing them https://ml-eu.globenewswire.com/media/60710381-ea35-4434-82a8-9801a1fcd55e/small/oh-tagline-logo-pos-3-jpg.jpg https://www.turkmenistanhealthnews.com/article/915551485-bionature-berberine-claims-evaluated-premium-berberine-ampk-activator-supplement-for-blood-sugar-metabolism-support Turkmenistan Health News en PressRelease 2026-05-27T22:30:00+00:00 BioNature Berberine Claims Evaluated: Premium Berberine AMPK Activator Supplement for Blood Sugar & Metabolism Support https://zingfast.com/wp-content/uploads/2026/05/BioNature-Berberine-1.jpg https://www.turkmenistanhealthnews.com/article/915534281-gala-health-high-quality-compounded-glp-1-weight-loss-hormone-therapy-hrt-support Turkmenistan Health News en PressRelease 2026-05-27T21:09:02+00:00 Gala Health: High-Quality Compounded GLP-1 Weight Loss & Hormone Therapy HRT Support https://zingfast.com/wp-content/uploads/2026/05/Gala-Health-High-Quality-Compounded-GLP-1-Weight-Loss.jpg https://www.turkmenistanhealthnews.com/article/915534091-cvrx-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-27T20:30:00+00:00 CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference https://ml.globenewswire.com/media/04c4feba-7841-4ac8-8ca5-6c03be383a0e/small/cvrx-outsmart-the-heart-logo-rgb-blue-png.png https://www.turkmenistanhealthnews.com/article/915534165-imagenebio-to-participate-in-2026-jefferies-global-healthcare-conference-in-new-york Turkmenistan Health News en PressRelease 2026-05-27T20:30:00+00:00 ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York https://ml.globenewswire.com/media/ccccc30d-a51c-48d7-9aec-6b542240c611/small/imagene-logo-green-jpg.jpg https://www.turkmenistanhealthnews.com/article/915534176-supernus-pharmaceuticals-to-participate-in-june-investor-conferences Turkmenistan Health News en PressRelease 2026-05-27T20:30:00+00:00 Supernus Pharmaceuticals to Participate in June Investor Conferences https://ml.globenewswire.com/media/1fc58442-511b-40c2-a8c0-f1e78b8437b4/small/supernus-pharmaceuticals-inc.jpg https://www.turkmenistanhealthnews.com/article/915534248-american-kidney-fund-expands-kidney-health-coach-program-with-educational-content-on-ckm-syndrome Turkmenistan Health News en PressRelease 2026-05-27T20:29:01+00:00 American Kidney Fund Expands Kidney Health Coach Program with Educational Content on CKM Syndrome https://ml.globenewswire.com/media/Y2MzYTc0ODYtYzc4Mi00YjU5LWEwZDUtNDBkNzQwMTQ2MzIyLTExMDkwNTItMjAyNi0wNS0yNy1lbg==/tiny/American-Kidney-Fund.png https://www.turkmenistanhealthnews.com/article/915534217-pacira-biosciences-mails-letter-to-stockholders-reiterating-confidence-in-the-company-s-strategic-direction-and-highly-qualified-nominees Turkmenistan Health News en PressRelease 2026-05-27T20:20:00+00:00 Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company’s Strategic Direction and Highly Qualified Nominees https://ml.globenewswire.com/media/df0aa20f-7cc2-417a-adb8-44534131eb8f/medium/figure-1.png https://www.turkmenistanhealthnews.com/article/915516974-oric-pharmaceuticals-to-participate-in-upcoming-investor-conferences Turkmenistan Health News en PressRelease 2026-05-27T20:05:00+00:00 ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/acbc0ad2-7a44-4ee7-b729-ab92d57ffafb/small/oric-png.png https://www.turkmenistanhealthnews.com/article/915516981-sana-biotechnology-to-present-at-june-2026-investor-conferences Turkmenistan Health News en PressRelease 2026-05-27T20:05:00+00:00 Sana Biotechnology to Present at June 2026 Investor Conferences https://ml.globenewswire.com/media/2e5b81be-ddf0-4a60-85f1-3f17c242e8c2/small/sana-biotechnology-jpg.jpg https://www.turkmenistanhealthnews.com/article/915517036-aktis-oncology-to-present-at-the-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-27T20:05:00+00:00 Aktis Oncology to Present at the Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/490bbb9a-2b27-4a72-8d7a-333387326d8b/small/aktis-rgb-png.png https://www.turkmenistanhealthnews.com/article/915517075-billiontoone-to-participate-in-the-william-blair-46th-annual-growth-stock-conference Turkmenistan Health News en PressRelease 2026-05-27T20:05:00+00:00 BillionToOne to Participate in the William Blair 46th Annual Growth Stock Conference https://ml.globenewswire.com/media/888ae54a-648f-4986-998b-84df416858c7/small/billion-to-one-logo-new-jpg.jpg https://www.turkmenistanhealthnews.com/article/915517369-relay-therapeutics-to-participate-in-two-upcoming-investor-conferences-in-june Turkmenistan Health News en PressRelease 2026-05-27T20:05:00+00:00 Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png https://www.turkmenistanhealthnews.com/article/915517575-zentalis-strengthens-commercial-leadership-with-appointments-of-shannon-campbell-to-board-of-directors-and-sarah-kelly-as-svp-of-commercial-strategy Turkmenistan Health News en PressRelease 2026-05-27T20:05:00+00:00 Zentalis Strengthens Commercial Leadership with Appointments of Shannon Campbell to Board of Directors and Sarah Kelly as SVP of Commercial Strategy https://ml.globenewswire.com/media/ecb98bea-7a9f-4319-874c-1911777a5a46/small/zentalis-logo-full-color-png.png https://www.turkmenistanhealthnews.com/article/915517092-ligand-to-participate-in-june-investor-conferences Turkmenistan Health News en PressRelease 2026-05-27T20:01:00+00:00 Ligand to Participate in June Investor Conferences https://ml.globenewswire.com/media/1fe91aa2-494e-4b30-89e8-cad771bbaabf/small/new-ligand-logo-png.png https://www.turkmenistanhealthnews.com/article/915516985-mannkind-to-present-at-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-27T20:00:00+00:00 MannKind to Present at Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/fc4da88e-772c-44f1-87a9-36ece175bc5b/small/mannkind-logo-rgb-1200x628-png.png https://www.turkmenistanhealthnews.com/article/915517081-cytokinetics-to-participate-in-june-investor-conferences Turkmenistan Health News en PressRelease 2026-05-27T20:00:00+00:00 Cytokinetics to Participate in June Investor Conferences https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://www.turkmenistanhealthnews.com/article/915517511-aquafit-claims-evaluated-the-2026-ice-water-hack-recipe-reveals-real-weight-loss-support-with-aqua-fit Turkmenistan Health News en PressRelease 2026-05-27T19:45:16+00:00 AquaFit Claims Evaluated: The 2026 Ice Water Hack Recipe Reveals Real Weight Loss Support with Aqua Fit https://zingfast.com/wp-content/uploads/2026/05/AquaFit-Ice-Water-Hack.jpg https://www.turkmenistanhealthnews.com/article/915517380-momcozy-launches-plus-baby-wipes-built-for-every-messy-milestone-99-purified-water-8-8-independently-tested-by-intertek Turkmenistan Health News en PressRelease 2026-05-27T19:30:00+00:00 Momcozy Launches Plus Baby Wipes Built for Every “Messy Milestone”: 99% Purified Water, 8″ × 8″, Independently Tested by Intertek https://ml.globenewswire.com/media/d97f9155-46e0-42cf-b53c-c8b0bc0f52e8/small/logo-20768-jpg.jpg https://www.turkmenistanhealthnews.com/article/915517475-drew-altman-founding-president-and-ceo-of-kff-announces-retirement-plans-board-appoints-larry-levitt-and-mollyann-brodie-as-next-leadership-team Turkmenistan Health News en PressRelease 2026-05-27T19:28:14+00:00 Drew Altman, Founding President and CEO of KFF, Announces Retirement Plans; Board Appoints Larry Levitt and Mollyann Brodie as Next Leadership Team https://ml.globenewswire.com/media/MTU4NzcwYjEtMDFlYy00NmQzLTk0NzktNzQ3ODcwNjFjOWI1LTUwMDE1NTcyNC0yMDI2LTA1LTI3LWVu/tiny/KFF.png https://www.turkmenistanhealthnews.com/article/915517384-brewdog-verwandelt-die-diesj-hrige-fu-ball-wm-in-ein-landesweites-sommerfest-rund-um-bier-bars-und-gro-e-spielmoment Turkmenistan Health News en PressRelease 2026-05-27T19:24:42+00:00 BrewDog verwandelt die diesjährige Fußball-WM in ein landesweites Sommerfest rund um Bier, Bars und große Spielmoment https://ml.globenewswire.com/media/2dbf85bb-5e30-4623-8f9b-931442240c05/small/tilraybrands-logo-fullcolor-rbg-horiz-01-png.png https://www.turkmenistanhealthnews.com/article/915517387-brewdog-transforme-le-tournoi-mondial-de-football-de-cet-t-en-une-c-l-bration-nationale-de-la-bi-re-des-bars-et-des-grands-moments-de-match Turkmenistan Health News en PressRelease 2026-05-27T19:24:42+00:00 BrewDog transforme le tournoi mondial de football de cet été en une célébration nationale de la bière, des bars et des grands moments de match https://ml.globenewswire.com/media/2dbf85bb-5e30-4623-8f9b-931442240c05/small/tilraybrands-logo-fullcolor-rbg-horiz-01-png.png https://www.turkmenistanhealthnews.com/article/915517349-pcca-launches-exoblue-a-new-compounding-base-designed-for-the-next-generation-of-personalized-skincare Turkmenistan Health News en PressRelease 2026-05-27T19:07:00+00:00 PCCA Launches ExoBlue™ — A New Compounding Base Designed for the Next Generation of Personalized Skincare https://ml.globenewswire.com/media/M2U5OTRlODMtZGU0MS00MDM3LWI0NjUtNTUzZmQ3NWUwOGRiLTEyMjE2NjAtMjAyNi0wNS0yNy1lbg==/tiny/PCCA.png https://www.turkmenistanhealthnews.com/article/915500085-sierra-tucson-names-dr-mark-j-helms-new-medical-director Turkmenistan Health News en PressRelease 2026-05-27T18:00:00+00:00 Sierra Tucson Names Dr. Mark J. Helms New Medical Director https://ml.globenewswire.com/media/ZTE4YjgwNDAtNmM1OS00OTMwLWJhZDQtMDVjNmYzNGJkNTJjLTEyMTQxOTktMjAyNi0wNS0yNy1lbg==/tiny/Sierra-Tucson.png https://www.turkmenistanhealthnews.com/article/915500132-father-s-day-gifts-for-dads-who-say-they-don-t-want-anything Turkmenistan Health News en PressRelease 2026-05-27T17:41:28+00:00 Father’s Day Gifts for Dads Who Say They Don’t Want Anything https://ml.globenewswire.com/media/b42ef3d9-5e83-474b-95ea-e8ec5fb696ac/medium/fathers-day-family-cooking-activity-with-raddish-kids-subscr.jpg https://www.turkmenistanhealthnews.com/article/915486449-vigortrix-male-enhancement-claims-evaluated-the-horse-gelatin-trick-for-men-s-stallion-like-vigor-boost-performance-support Turkmenistan Health News en PressRelease 2026-05-27T17:27:41+00:00 Vigortrix Male Enhancement Claims Evaluated: The Horse Gelatin Trick for Men's Stallion-Like Vigor Boost Performance Support https://zingfast.com/wp-content/uploads/2026/05/Vigortrix-Male-Enhancement.jpg https://www.turkmenistanhealthnews.com/article/915473020-5-nutrition-boosting-tips-to-spread-protein-throughout-the-day Turkmenistan Health News en PressRelease 2026-05-27T15:41:56+00:00 5 Nutrition-Boosting Tips to Spread Protein Throughout the Day https://ml.globenewswire.com/Resource/Download/967cbcb5-5206-4864-a80e-a498d2e189d2/17927-1.jpg https://www.turkmenistanhealthnews.com/article/915459548-zealand-pharma-to-participate-in-the-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-27T15:00:00+00:00 Zealand Pharma to participate in the Jefferies Global Healthcare Conference https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://www.turkmenistanhealthnews.com/article/915459995-eli-lilly-s-oral-glp-1-foundayo-trails-novo-nordisk-s-wegovy-pill-in-early-obesity-launch-uptake-according-to-spherix-global-insights Turkmenistan Health News en PressRelease 2026-05-27T14:40:47+00:00 Eli Lilly’s Oral GLP-1 Foundayo Trails Novo Nordisk’s Wegovy Pill in Early Obesity Launch Uptake, According to Spherix Global Insights https://ml.globenewswire.com/media/YmQ4ODE5ODQtMzZlYi00YzliLTg3OWYtM2FlZDkxMzg5ZDE0LTUwMDE1MTQyOC0yMDI2LTA1LTI3LWVu/tiny/Spherix-Global-Insights.png https://www.turkmenistanhealthnews.com/article/915459903-update-conexeu-sciences-initiates-preclinical-development-program-for-b-r-e-a-s-t-bioregenerative-matrix-platform-with-wake-forest-institute-for Turkmenistan Health News en PressRelease 2026-05-27T14:36:45+00:00 UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine https://ml.globenewswire.com/media/4c60c2e0-15ea-48ee-917b-69dd6218f181/medium/remdo.png https://www.turkmenistanhealthnews.com/article/915459728-sun-sentinel-names-gift-of-life-marrow-registry-a-south-florida-top-workplace-for-2026 Turkmenistan Health News en PressRelease 2026-05-27T14:20:48+00:00 Sun Sentinel Names Gift of Life Marrow Registry a South Florida Top Workplace for 2026 https://ml.globenewswire.com/media/5641e769-0169-4a15-bedf-8a09e0c681d7/small/gol-4c-orange-jpg.jpg https://www.turkmenistanhealthnews.com/article/915459555-medicana-health-group-opens-medicana-longevity-center-in-istanbul-led-by-prof-dr-osman-m-ft-o-lu Turkmenistan Health News en PressRelease 2026-05-27T14:00:00+00:00 Medicana Health Group Opens Medicana Longevity Center In Istanbul, Led By Prof. Dr. Osman Müftüoğlu https://ml-eu.globenewswire.com/media/fba660e7-f137-4375-8f6d-218262c58234/medium/prof-dr-osman-muftuoglu.jpg https://www.turkmenistanhealthnews.com/article/915459636-simple-s-avo-named-best-virtual-health-coach-in-medtech-breakthrough-awards-program Turkmenistan Health News en PressRelease 2026-05-27T14:00:00+00:00 Simple’s Avo™ Named “Best Virtual Health Coach” in MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://www.turkmenistanhealthnews.com/article/915459664-therini-bio-doses-first-patients-in-phase-1b-trial-of-novel-anti-inflammatory-therapy-thn391-for-diabetic-macular-edema Turkmenistan Health News en PressRelease 2026-05-27T14:00:00+00:00 Therini Bio Doses First Patients in Phase 1b Trial of Novel Anti-Inflammatory Therapy, THN391, for Diabetic Macular Edema https://ml.globenewswire.com/media/e0ab6ccc-6b1f-42fa-9a1b-35e6656f214f/small/therini-logo-png.png https://www.turkmenistanhealthnews.com/article/915447070-biomx-appoints-idf-colonel-res-roy-timor-rousso-as-chief-business-officer-to-strengthen-defense-security-operations Turkmenistan Health News en PressRelease 2026-05-27T13:40:00+00:00 BiomX Appoints IDF Colonel (res.) Roy Timor-Rousso as Chief Business Officer to Strengthen Defense & Security Operations https://ml.globenewswire.com/media/Y2VjMTRhYzMtMmUzMy00NDA1LWI4NGEtNzA0MGQwMjBhOGU1LTEzMjE4NzEtMjAyNi0wNS0yNy1lbg==/tiny/BiomX.png https://www.turkmenistanhealthnews.com/article/915446378-pediatric-eeg-interpretation-now-available-to-partner-hospitals-nationwide-through-dedicated-subspecialty-pathway Turkmenistan Health News en PressRelease 2026-05-27T13:30:00+00:00 Pediatric EEG Interpretation Now Available to Partner Hospitals Nationwide Through Dedicated Subspecialty Pathway https://ml.globenewswire.com/media/YTA4ZmM5NTQtNTA5MC00MWE4LTkxNGYtODEyOTZiMjNkNzY3LTUwMDE0OTY0OS0yMDI2LTA1LTI3LWVu/tiny/TeleSpecialists.png https://www.turkmenistanhealthnews.com/article/915446382-myriad-genetics-highlights-data-showing-broad-clinical-utility-of-precise-mrd-assay-at-2026-asco-annual-meeting Turkmenistan Health News en PressRelease 2026-05-27T13:05:00+00:00 Myriad Genetics Highlights Data Showing Broad Clinical Utility of Precise MRD Assay at 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/5cb679cf-5a10-4b95-8cf7-fd1d0b56721a/small/myriad-s-stacked-png.png https://www.turkmenistanhealthnews.com/article/915446523-mannkind-to-showcase-new-data-at-ada-2026-advancing-understanding-of-inhaled-insulin-afrezza-in-pediatric-care-pregnancy-and-use-with-automated Turkmenistan Health News en PressRelease 2026-05-27T13:05:00+00:00 MannKind to Showcase New Data at ADA 2026 Advancing Understanding of Inhaled Insulin (Afrezza®) in Pediatric Care, Pregnancy and Use with Automated Insulin Delivery (AID) Systems https://ml.globenewswire.com/media/fc4da88e-772c-44f1-87a9-36ece175bc5b/small/mannkind-logo-rgb-1200x628-png.png https://www.turkmenistanhealthnews.com/article/915446228-southern-california-reproductive-center-joins-nucleus-ivf-network-as-patient-demand-accelerates Turkmenistan Health News en PressRelease 2026-05-27T13:00:00+00:00 Southern California Reproductive Center Joins Nucleus IVF+ Network as Patient Demand Accelerates https://ml.globenewswire.com/media/8815da0e-8947-4709-8064-6b033ee4c530/small/nucleus-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/915446238-asymbio-showcases-comprehensive-conjugation-toolbox-to-support-process-development-for-next-generation-bioconjugates Turkmenistan Health News en PressRelease 2026-05-27T13:00:00+00:00 AsymBio Showcases Comprehensive Conjugation Toolbox to Support Process Development for Next-Generation Bioconjugates https://ml.globenewswire.com/media/1d67b343-a22b-464b-978b-2ce7a34d4967/small/20260113-logo-for-enewsletter-jpg.jpg https://www.turkmenistanhealthnews.com/article/915446255-jenavalve-appoints-edward-sarnowski-as-chief-technology-officer Turkmenistan Health News en PressRelease 2026-05-27T13:00:00+00:00 JenaValve Appoints Edward Sarnowski as Chief Technology Officer https://ml.globenewswire.com/media/a1ab2446-a463-4b8f-bc18-26a5ca117176/small/jv-logo-h-rgb-l-1607-png.png https://www.turkmenistanhealthnews.com/article/915446258-privia-health-enters-new-jersey Turkmenistan Health News en PressRelease 2026-05-27T13:00:00+00:00 Privia Health Enters New Jersey https://ml.globenewswire.com/media/cbd80725-9c2b-43fd-8212-65414fe6bc0e/small/priv-jpg.jpg https://www.turkmenistanhealthnews.com/article/915446278-paragonix-announces-launch-of-concert-dcd-clinical-trial-in-collaboration-with-uw-medicine-to-maximize-heart-transplant-utilization Turkmenistan Health News en PressRelease 2026-05-27T13:00:00+00:00 Paragonix Announces Launch of CONCERT-DCD Clinical Trial in Collaboration with UW Medicine to Maximize Heart Transplant Utilization https://ml.globenewswire.com/media/5b56fec1-dc1d-480e-8a0b-aa723d7e7cf9/small/paragonix-getinge-bluecenter-png.png https://www.turkmenistanhealthnews.com/article/915446527-palisade-bio-to-participate-in-the-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-27T13:00:00+00:00 Palisade Bio to Participate in the Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/0beaede8-1c7c-4f77-84a7-b1efd54c343c/small/logo-png.png https://www.turkmenistanhealthnews.com/article/915446529-kal-o-launches-auvi-q-speaks-up-focused-on-real-world-preparedness-for-anaphylaxis Turkmenistan Health News en PressRelease 2026-05-27T13:00:00+00:00 Kaléo Launches AUVI-Q Speaks Up™ Focused on Real-World Preparedness for Anaphylaxis https://ml.globenewswire.com/media/MzFjN2I4NzAtMmJhYy00MjFiLWJiOTMtOTk4NzdiY2RhNGYxLTUwMDE2MTM4Ni0yMDI2LTA1LTI3LWVu/tiny/Kal-o.png https://www.turkmenistanhealthnews.com/article/915446601-omada-health-to-participate-in-goldman-sachs-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-27T13:00:00+00:00 Omada Health to Participate in Goldman Sachs Global Healthcare Conference https://ml.globenewswire.com/media/f60ce57f-1859-49c3-9423-9562cf46cb64/small/omada-horizontal-color-r-png.png https://www.turkmenistanhealthnews.com/article/915446709-after-fifty-years-of-implants-a-newly-public-biotech-is-trying-to-rebuild-the-breast-instead Turkmenistan Health News en PressRelease 2026-05-27T13:00:00+00:00 After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead https://ml.globenewswire.com/media/2a5a0234-e92f-4fde-9226-4c200051a974/small/95680-jpg.jpg https://www.turkmenistanhealthnews.com/article/915446483-aim-immunotech-announces-emerging-ebola-opportunity-for-ampligen-amid-escalating-global-health-concerns-and-who-emergency-declaration Turkmenistan Health News en PressRelease 2026-05-27T12:47:00+00:00 AIM ImmunoTech Announces Emerging Ebola Opportunity for Ampligen Amid Escalating Global Health Concerns and WHO Emergency Declaration https://ml.globenewswire.com/media/8e85b83b-047f-4f99-9c51-1aa232ffe9bb/small/aimlogo-jpg.jpg https://www.turkmenistanhealthnews.com/article/915446231-milestone-scientific-highlights-growing-clinical-adoption-and-expanding-physician-acceptance-of-compuflo-across-epidural-neuromodulation-and Turkmenistan Health News en PressRelease 2026-05-27T12:45:00+00:00 Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures https://ml.globenewswire.com/media/408ad3c5-6ad3-41bd-9763-356666216796/small/milestonelogo-rgb-final-jpg.jpg https://www.turkmenistanhealthnews.com/article/915446608-traws-pharma-announces-antiviral-program-targeting-ongoing-hantavirus-and-ebola-virus-disease-outbreaks Turkmenistan Health News en PressRelease 2026-05-27T12:45:00+00:00 Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks https://ml.globenewswire.com/media/1eb1780a-724e-4555-ab4d-455e27d18544/small/traws-pharma-blue-png.png https://www.turkmenistanhealthnews.com/article/915433668-20-20-biolabs-multi-cancer-early-detection-blood-test-selected-by-state-of-vermont-to-screen-up-to-4-500-firefighters Turkmenistan Health News en PressRelease 2026-05-27T12:31:00+00:00 20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters https://ml.globenewswire.com/media/bcaf95ca-9983-408c-bc61-646e4ee2f925/small/2020-biolabs-logo-png.png https://www.turkmenistanhealthnews.com/article/915433069-altimmune-to-participate-in-upcoming-investor-conferences Turkmenistan Health News en PressRelease 2026-05-27T12:30:00+00:00 Altimmune to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/362fbdfa-dc07-456c-9908-9e042540158a/small/altimmune-logo-png.png https://www.turkmenistanhealthnews.com/article/915433310-eom-pharmaceutical-holdings-reports-fda-clearance-of-an-ind-for-a-clinical-trial-in-cachectic-cancer-patients Turkmenistan Health News en PressRelease 2026-05-27T12:30:00+00:00 EOM Pharmaceutical Holdings Reports FDA Clearance of an IND for a Clinical Trial in Cachectic Cancer Patients https://ml.globenewswire.com/media/NzlmMThmZDYtY2UwOS00MjQ2LWI3ZDgtMDgwNzI2MmVlMGJkLTEzMTk3NTAtMjAyNi0wNS0yNy1lbg==/tiny/EOM-Pharmaceuticals.png https://www.turkmenistanhealthnews.com/article/915433670-tomi-environmental-solutions-highlights-expanded-market-opportunity-following-cdc-published-hantavirus-study-and-rising-global-ebola-concerns Turkmenistan Health News en PressRelease 2026-05-27T12:30:00+00:00 TOMI Environmental Solutions Highlights Expanded Market Opportunity Following CDC-Published Hantavirus Study and Rising Global Ebola Concerns https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg https://www.turkmenistanhealthnews.com/article/915433744-conexeu-sciences-initiates-preclinical-development-program-for-b-r-e-a-s-t-bioregenerative-matrix-platform-with-wake-forest-institute-for Turkmenistan Health News en PressRelease 2026-05-27T12:30:00+00:00 Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine https://ml.globenewswire.com/media/4c60c2e0-15ea-48ee-917b-69dd6218f181/medium/remdo.png https://www.turkmenistanhealthnews.com/article/915433538-ernexa-therapeutics-successfully-completes-key-manufacturing-and-ind-preparation-milestones-for-erna-101-toward-first-in-human-clinical-development Turkmenistan Health News en PressRelease 2026-05-27T12:11:00+00:00 Ernexa Therapeutics Successfully Completes Key Manufacturing and IND Preparation Milestones for ERNA-101 Toward First-in-Human Clinical Development https://ml.globenewswire.com/media/bb12f9ec-b7e7-4d8c-92df-cf27e238c398/small/ernexa-color-png.png https://www.turkmenistanhealthnews.com/article/915433492-premia-and-lind-form-lind-asia-to-expand-ai-powered-clinical-trial-screening-across-asia-pacific Turkmenistan Health News en PressRelease 2026-05-27T12:07:00+00:00 PREMIA and Lind Form Lind Asia to Expand AI-Powered Clinical Trial Screening Across Asia-Pacific https://ml.globenewswire.com/media/a3d4adaf-2ea4-4184-b16c-77ad70158194/small/premia-logo-png.png https://www.turkmenistanhealthnews.com/article/915433006-sionna-therapeutics-to-participate-in-upcoming-june-2026-investor-conferences Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 Sionna Therapeutics to Participate in Upcoming June 2026 Investor Conferences https://ml.globenewswire.com/media/0cda8c25-e758-4f0d-86f2-875df8411a9a/small/sionna-png.png https://www.turkmenistanhealthnews.com/article/915433011-opus-genetics-to-present-at-the-2026-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 Opus Genetics to Present at the 2026 Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/468baef1-3b2d-4353-a17e-cb41b45ee6ef/small/opus-rgb-r-jpg.jpg https://www.turkmenistanhealthnews.com/article/915433016-collegium-to-participate-in-2026-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 Collegium to Participate in 2026 Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/c9077b27-1a69-42a5-9f77-e39124f4d2a2/small/collegium-rgb-large-r-jpg.jpg https://www.turkmenistanhealthnews.com/article/915433019-galectin-therapeutics-presents-new-easl-2026-oral-and-poster-analyses-demonstrating-belapectin-s-potential-to-modify-disease-progression-in-advanced Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 Galectin Therapeutics Presents New EASL 2026 Oral and Poster Analyses Demonstrating Belapectin’s Potential to Modify Disease Progression in Advanced MASH Cirrhosis https://ml.globenewswire.com/media/dd593f5d-61a4-4e6b-87d3-b9deb9f5d33f/small/galectin-jpg.jpg https://www.turkmenistanhealthnews.com/article/915433032-viromissile-idov-safe-phase-1-data-to-be-presented-at-the-2026-asco-annual-meeting Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 ViroMissile IDOV-Safe Phase 1 Data to Be Presented at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/ff7b467c-236d-45ab-998d-fbd5dd6293e4/small/viromissile-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/915433064-avalyn-to-participate-in-the-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 Avalyn to Participate in the Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/84d7bff4-ce17-433b-8c71-aa20c30f9f43/small/avalyn-logo-final-png.png https://www.turkmenistanhealthnews.com/article/915433085-annexon-to-participate-in-upcoming-june-investor-conferences Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 Annexon to Participate in Upcoming June Investor Conferences https://ml.globenewswire.com/media/fda933a1-e95d-4cae-8894-7b2354118e20/small/annexon-logo-rgb-png.png https://www.turkmenistanhealthnews.com/article/915433092-pacira-biosciences-reports-real-world-study-showing-exparel-use-was-associated-with-reduced-opioid-use-and-healthcare-costs-in-patients-undergoing Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty https://ml.globenewswire.com/media/3e502c92-e576-46b6-b602-a177ab0f5044/small/pacira-biosciences-tm-logo-rgb-v2025-300dpi-adj-png.png https://www.turkmenistanhealthnews.com/article/915433197-join-biovie-s-exclusive-live-investor-webinar-and-q-and-a-session-on-june-2 Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 Join BioVie’s Exclusive Live Investor Webinar and Q and A Session on June 2 https://ml.globenewswire.com/media/f437d04b-c089-46eb-bca8-7ef64f68bc9b/small/biovie-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/915433226-cogent-biosciences-announces-participation-in-the-2026-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 Cogent Biosciences Announces Participation in the 2026 Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/2b8cbfab-a4de-4e17-bdd6-7ef597a95d2e/small/cogent-biosciences-logo-rgb-png.png https://www.turkmenistanhealthnews.com/article/915433231-new-reduce-it-analysis-presented-at-the-european-atherosclerosis-society-eas-congress-2026-suggests-risk-weighted-apob-may-improve-identification Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia https://ml.globenewswire.com/media/00eeab93-e634-4279-86b3-7973c2a21623/small/amarin-logo-jpeg-jpg.jpg https://www.turkmenistanhealthnews.com/article/915433315-4dmt-to-participate-in-upcoming-investor-conferences Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 4DMT to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png https://www.turkmenistanhealthnews.com/article/915433324-rectify-pharmaceuticals-presents-new-translational-data-at-easl-2026-supporting-rty-406-its-clinical-candidate-for-the-treatment-of-primary Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 Rectify Pharmaceuticals Presents New Translational Data at EASL 2026 Supporting RTY-406, its Clinical Candidate for the Treatment of Primary Sclerosing Cholangitis https://ml.globenewswire.com/media/bdac6aa0-18b4-4330-98a1-e9673a671b69/small/rectify-logo-color-jpg.jpg https://www.turkmenistanhealthnews.com/article/915433416-mineralys-therapeutics-to-participate-in-the-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 Mineralys Therapeutics to Participate in the Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/2f3e6873-8e64-406e-832e-7df0f6d79a56/small/mineralys-therapeutics-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/915433420-noom-brings-the-lab-to-the-living-room-new-at-home-biomarkers-test-kit-enables-members-to-see-exactly-how-glp-1s-and-healthy-habits-are-transforming Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 Noom Brings the Lab to the Living Room: New At-Home Biomarkers Test Kit Enables Members to See Exactly How GLP-1s and Healthy Habits Are Transforming Their Health https://ml.globenewswire.com/media/662f3c13-0ec5-4b93-9721-5dfb02f96e6d/medium/healthy-bmi-hidden-risks.png https://www.turkmenistanhealthnews.com/article/915433451-erasca-to-present-at-the-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 Erasca to Present at the Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/266fe248-70d0-4904-b12e-e0d5a990f816/small/erascatm-logo-png.png https://www.turkmenistanhealthnews.com/article/915433478-micron-biomedical-expands-leadership-to-mobilize-for-pivotal-studies-and-commercialization-of-first-needle-free-dissolvable-vaccines-and-therapeutics Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 Micron Biomedical Expands Leadership to Mobilize for Pivotal Studies and Commercialization of First Needle-Free Dissolvable Vaccines and Therapeutics https://ml.globenewswire.com/media/58c5c48d-11e7-43f2-93fd-345c1713ad82/medium/new-cfo-at-micron-biomedical-commercializing-needle-free-vac.jpg https://www.turkmenistanhealthnews.com/article/915433481-mesa-labs-announces-fourth-quarter-and-fiscal-year-2026-results Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results https://ml.globenewswire.com/media/ff66b401-9246-47b9-accc-2f553d346c5c/small/mesalogo-jpg.jpg https://www.turkmenistanhealthnews.com/article/915433645-callio-therapeutics-to-present-phase-1-trial-design-of-clio-8221-novel-dual-payload-adc-at-asco-2026 Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 Callio Therapeutics to Present Phase 1 Trial Design of CLIO-8221, Novel Dual-Payload ADC, at ASCO 2026 https://ml.globenewswire.com/media/3511fd62-eaba-4921-a3da-4e0b00d976e6/small/callio-logo-stacked-default-png.png https://www.turkmenistanhealthnews.com/article/915433675-health-coalition-to-provide-details-re-giant-march-thursday-to-demand-doug-ford-stop-his-unprecedented-privatization-of-our-public-hospital-services Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 Health Coalition to provide details re. giant march Thursday to demand Doug Ford stop his unprecedented privatization of our public hospital services https://ml.globenewswire.com/media/fdd00e9f-f066-4244-85e8-d12e6d1b760c/small/screen-shot-2023-09-14-at-1-49-15-pm-png.png https://www.turkmenistanhealthnews.com/article/915433779-madrigal-presents-data-demonstrating-rezdiffra-reduced-markers-of-cardiovascular-and-liver-related-risk-in-patients-with-mash Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 Madrigal Presents Data Demonstrating Rezdiffra Reduced Markers of Cardiovascular and Liver-Related Risk in Patients with MASH https://ml.globenewswire.com/media/8fec8de1-1a2e-4f6c-a679-fc43002276ba/small/madrigal-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/915433797-cdt-announces-canadian-patent-for-azd5904-in-male-infertility Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 CDT Announces Canadian Patent for AZD5904 in Male Infertility https://ml.globenewswire.com/media/ZjQ5NTc3NjItY2I1Yy00OWRlLTlmNWMtNjQzYzZjYTYxNGFjLTEyNzQxMDItMjAyNi0wNS0yNy1lbg==/tiny/CDT-Equity-Inc-.png https://www.turkmenistanhealthnews.com/article/915433808-hemab-therapeutics-to-participate-in-the-2026-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 Hemab Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/c5d70227-b7a8-4280-bd6b-389252a2e5b3/small/hemab-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/915433812-enlivex-treasury-portfolio-update-rain-protocol-jumps-into-top-three-global-prediction-markets-in-league-table-following-100m-in-additional Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 Enlivex Treasury Portfolio Update: Rain Protocol Jumps Into Top Three Global Prediction Markets In League Table Following $100M In Additional Liquidity https://ml.globenewswire.com/media/27d4e006-8709-4fd1-8341-5b58381487d4/small/picture1-jpg.jpg https://www.turkmenistanhealthnews.com/article/915433842-new-impact-phase-2b-data-highlight-concurrent-improvements-across-multiple-non-invasive-markers-and-qfibrosis-measured-fibrosis-regression-with Turkmenistan Health News en PressRelease 2026-05-27T12:00:00+00:00 New IMPACT Phase 2b Data Highlight Concurrent Improvements Across Multiple Non-Invasive Markers and qFibrosis-Measured Fibrosis Regression with Pemvidutide in MASH at EASL 2026 https://ml.globenewswire.com/media/362fbdfa-dc07-456c-9908-9e042540158a/small/altimmune-logo-png.png https://www.turkmenistanhealthnews.com/article/915433775-newcelx-ltd-submits-pre-ind-package-to-the-fda-for-ncel-101-for-the-treatment-of-type-1-diabetes Turkmenistan Health News en PressRelease 2026-05-27T11:55:00+00:00 NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes https://ml.globenewswire.com/media/ac801d4e-6ea5-4452-87c2-aa6a05bec73c/small/logo-positive-2x-jpg.jpg https://www.turkmenistanhealthnews.com/article/915433656-hcw-biologics-exercised-option-to-regain-full-rights-for-two-commercial-ready-reagents-from-wugen Turkmenistan Health News en PressRelease 2026-05-27T11:45:00+00:00 HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen https://ml.globenewswire.com/media/5689edc3-6997-43a0-a20c-b34dc5f99b0f/small/hcw-logo-full-color-600x-jpeg-2-jpg.jpg https://www.turkmenistanhealthnews.com/article/915420377-transforming-rural-health-care-through-a-first-of-its-kind-collaborative Turkmenistan Health News en PressRelease 2026-05-27T11:30:00+00:00 Transforming Rural Health Care Through a First-of-its-Kind Collaborative https://ml.globenewswire.com/media/39a718b6-f27d-4043-bde4-fd7d4c046911/small/pharmerica-logo-no-tag-png.png https://www.turkmenistanhealthnews.com/article/915420920-medline-announces-participation-in-upcoming-investor-conferences Turkmenistan Health News en PressRelease 2026-05-27T11:30:00+00:00 Medline announces participation in upcoming investor conferences https://ml.globenewswire.com/media/70e45830-32e3-4232-b15b-7e43c436de41/small/log-medline-1200-630-center-png.png https://www.turkmenistanhealthnews.com/article/915420930-bridgebio-announces-fda-acceptance-and-priority-review-of-nda-for-bbp-418-for-lgmd2i-r9 Turkmenistan Health News en PressRelease 2026-05-27T11:30:00+00:00 BridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9 https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://www.turkmenistanhealthnews.com/article/915420939-context-therapeutics-to-present-at-the-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-27T11:30:00+00:00 Context Therapeutics to Present at the Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/67b45666-397e-4c48-af45-ffd653bbfddf/small/context-therapeutics-inc.jpg https://www.turkmenistanhealthnews.com/article/915421065-tg-therapeutics-announces-positive-topline-results-from-phase-3-enhance-trial Turkmenistan Health News en PressRelease 2026-05-27T11:30:00+00:00 TG Therapeutics Announces Positive Topline Results from Phase 3 ENHANCE Trial https://ml.globenewswire.com/media/0e613f5f-8c22-4c63-a73b-c08cc0fbec64/small/tgtx-2021-logo.jpg https://www.turkmenistanhealthnews.com/article/915421255-palvella-therapeutics-strengthens-qtorin-pitavastatin-intellectual-property-with-yale-licensed-u-s-patent-providing-protection-into-2043 Turkmenistan Health News en PressRelease 2026-05-27T11:30:00+00:00 Palvella Therapeutics Strengthens QTORIN™ Pitavastatin Intellectual Property with Yale-Licensed U.S. Patent Providing Protection into 2043 https://ml.globenewswire.com/media/83fd569b-5e6c-46ad-882a-6430f8ab755a/small/palvella-2025-logo-new-jpg.jpg https://www.turkmenistanhealthnews.com/article/915421257-jupiter-neurosciences-announces-patient-enrollment-underway-in-phase-2a-reset-trial-in-parkinson-s-disease Turkmenistan Health News en PressRelease 2026-05-27T11:30:00+00:00 Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson’s Disease https://ml.globenewswire.com/media/4e829d7e-ecf6-46ad-98fe-479755d626e1/small/image-png.png https://www.turkmenistanhealthnews.com/article/915420264-reprogram-biosciences-closes-seed-financing-to-advance-tumor-cell-reprogramming-therapeutics Turkmenistan Health News en PressRelease 2026-05-27T11:13:00+00:00 Reprogram Biosciences Closes Seed Financing to Advance Tumor Cell Reprogramming Therapeutics https://ml.globenewswire.com/media/ZDhmOGFjMDgtNjdiZC00ZTUzLWIyNjItMDI5M2RlYTVkNTFlLTEzMjM2MTMtMjAyNi0wNS0yNy1lbg==/tiny/Reprogram-Biosciences-Inc-.png https://www.turkmenistanhealthnews.com/article/915421252-maze-therapeutics-to-participate-in-two-upcoming-investor-conferences Turkmenistan Health News en PressRelease 2026-05-27T11:03:06+00:00 Maze Therapeutics to Participate in Two Upcoming Investor Conferences https://ml.globenewswire.com/media/20759f53-8fbe-4af8-9fc1-3a4a4ac5c195/small/lol-png.png https://www.turkmenistanhealthnews.com/article/915420353-invivyd-to-participate-in-upcoming-investor-events Turkmenistan Health News en PressRelease 2026-05-27T11:01:00+00:00 Invivyd to Participate in Upcoming Investor Events https://ml.globenewswire.com/media/7bf12f50-1073-4ce7-81ac-89426c07add3/small/untitled-design-2-png.png https://www.turkmenistanhealthnews.com/article/915420168-mitorx-therapeutics-to-present-new-preclinical-data-on-mtrx31-its-novel-mitochondrial-targeted-small-molecule-at-the-american-diabetes-association-s Turkmenistan Health News en PressRelease 2026-05-27T11:00:00+00:00 MitoRx Therapeutics to present new preclinical data on MTRX31, its novel mitochondrial-targeted small molecule at the American Diabetes Association’s 2026 Scientific Sessions https://ml-eu.globenewswire.com/media/70bd30fd-dc3b-4a8b-a8ab-06f0b6577994/small/download-png.png https://www.turkmenistanhealthnews.com/article/915420219-balchem-corporation-to-participate-in-the-wells-fargo-industrials-conference-on-june-10-2026 Turkmenistan Health News en PressRelease 2026-05-27T11:00:00+00:00 Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026 https://ml.globenewswire.com/media/922857f8-0f15-4509-ae78-b26aa1b5893e/small/balchem-jpg.jpg https://www.turkmenistanhealthnews.com/article/915420248-l-association-canadienne-de-dermatologie-en-partenariat-avec-m-lanome-canada-offrira-des-d-pistages-gratuits-du-cancer-de-la-peau-sur-la-colline-du Turkmenistan Health News en PressRelease 2026-05-27T11:00:00+00:00 L’Association canadienne de dermatologie, en partenariat avec Mélanome Canada, offrira des dépistages gratuits du cancer de la peau sur la Colline du Parlement https://ml.globenewswire.com/media/d0bcb869-44a1-4b37-aaef-331e0ffd3be9/medium/dermatologue-examinant-un-nvus.jpeg https://www.turkmenistanhealthnews.com/article/915420267-canadian-dermatology-association-in-partnership-with-melanoma-canada-offer-free-skin-cancer-screenings-on-parliament-hill Turkmenistan Health News en PressRelease 2026-05-27T11:00:00+00:00 Canadian Dermatology Association in Partnership with Melanoma Canada Offer Free Skin Cancer Screenings on Parliament Hill https://ml.globenewswire.com/media/d0bcb869-44a1-4b37-aaef-331e0ffd3be9/medium/dermatologist-examining-a-mole.jpeg https://www.turkmenistanhealthnews.com/article/915420295-kymera-therapeutics-to-participate-in-fireside-chat-at-the-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-27T11:00:00+00:00 Kymera Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/4d3d3283-c57d-401e-9e1b-53f17e22d76b/small/kymera-logo-rgb-denim-marigold-high-res-png.png https://www.turkmenistanhealthnews.com/article/915420307-tonix-pharmaceuticals-announces-publication-of-phase-1-clinical-data-of-tnx-1500-an-fc-modified-anti-cd40l-cd154-monoclonal-antibody-in-the Turkmenistan Health News en PressRelease 2026-05-27T11:00:00+00:00 Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology https://ml.globenewswire.com/media/16aad249-3d33-4501-b3d9-118a703fa46e/small/tonix2-jpg.jpg https://www.turkmenistanhealthnews.com/article/915420344-satellos-to-participate-in-upcoming-investor-conferences Turkmenistan Health News en PressRelease 2026-05-27T11:00:00+00:00 Satellos to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/3fe5e759-e0bb-4bc7-9979-e58a67f5f684/small/satellos-logo-gradient-black-png.png https://www.turkmenistanhealthnews.com/article/915420351-atea-pharmaceuticals-presents-new-drug-drug-interaction-results-supporting-potential-best-in-class-profile-of-the-regimen-of-bemnifosbuvir-and Turkmenistan Health News en PressRelease 2026-05-27T11:00:00+00:00 Atea Pharmaceuticals Presents New Drug-Drug Interaction Results Supporting Potential Best-in-Class Profile of the Regimen of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at EASL Congress 2026 https://ml.globenewswire.com/media/1506ab30-7618-4ed0-98de-e3815adb3aa6/small/avir-png.png https://www.turkmenistanhealthnews.com/article/915420811-axsome-therapeutics-to-participate-in-upcoming-investor-conferences Turkmenistan Health News en PressRelease 2026-05-27T11:00:00+00:00 Axsome Therapeutics to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/1186f248-bfb6-4258-a391-f2ffd94c5d76/small/axsome-r-morpheus-logo-pos-rgb-png.png https://www.turkmenistanhealthnews.com/article/915420831-brewdog-turns-this-summer-s-global-football-tournament-into-a-nationwide-celebration-of-beer-bars-and-big-match-moments Turkmenistan Health News en PressRelease 2026-05-27T11:00:00+00:00 BrewDog Turns This Summer’s Global Football Tournament into a Nationwide Celebration of Beer, Bars and Big Match Moments https://ml.globenewswire.com/media/b5523175-9d1b-4d94-bacb-3fd7c1f46f42/medium/brewdog-banner-2.jpeg https://www.turkmenistanhealthnews.com/article/915420875-leonabio-to-participate-in-upcoming-medical-and-industry-meetings-in-june Turkmenistan Health News en PressRelease 2026-05-27T11:00:00+00:00 LeonaBio to Participate in Upcoming Medical and Industry Meetings in June https://ml.globenewswire.com/media/84ac024a-139b-463f-a43f-ed787a66c0fd/small/image1-jpg.jpg https://www.turkmenistanhealthnews.com/article/915420877-sagimet-biosciences-presents-two-posters-at-easl-2026-on-denifanstat-resmetirom-combination-in-mash Turkmenistan Health News en PressRelease 2026-05-27T11:00:00+00:00 Sagimet Biosciences Presents Two Posters at EASL 2026 on Denifanstat/Resmetirom Combination in MASH https://ml.globenewswire.com/media/e944daed-3f71-402b-bb23-82149e5c0d26/small/sagimet-logo-for-light-bg-fin-png.png https://www.turkmenistanhealthnews.com/article/915420908-harrow-to-present-at-william-blair-s-46th-annual-growth-stock-conference Turkmenistan Health News en PressRelease 2026-05-27T11:00:00+00:00 Harrow to Present at William Blair’s 46th Annual Growth Stock Conference https://ml.globenewswire.com/media/8e0382bf-e00a-4591-87aa-4e90001aabea/small/bw-harrow-logo-cmyk-wtag-wr-jpg.jpg https://www.turkmenistanhealthnews.com/article/915420909-korro-to-present-at-the-2026-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-27T11:00:00+00:00 Korro to Present at the 2026 Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/d49fc3c4-5cf6-4b89-8434-2eadfff25c26/small/korro-logo-rgb-jpg.jpg https://www.turkmenistanhealthnews.com/article/915420913-biocryst-to-present-new-hae-data-from-orladeyo-berotralstat-and-navenibart-at-the-2026-european-academy-of-allergy-and-clinical-immunology-annual Turkmenistan Health News en PressRelease 2026-05-27T11:00:00+00:00 BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting https://ml.globenewswire.com/media/8b033909-1a3c-4811-b07b-fe03b12e00d2/small/biocryst-primarylogo-r-2c-rgb-jpg.jpg https://www.turkmenistanhealthnews.com/article/915420916-x4-pharmaceuticals-to-present-at-the-2026-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-27T11:00:00+00:00 X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/9c8d99a6-5cb7-4826-ae93-6c84d7f84355/small/x4-logo-png.png https://www.turkmenistanhealthnews.com/article/915420968-nrx-pharmaceuticals-nasdaq-nrxp-subsidiary-hope-therapeutics-becomes-first-commercial-site-to-deploy-zeta-surgical-s-fda-cleared-zeta-tms Turkmenistan Health News en PressRelease 2026-05-27T11:00:00+00:00 NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System https://ml.globenewswire.com/media/d879f1ff-d5d7-48d7-9731-c881b469d873/small/nrx-logo-300dpi-png.png https://www.turkmenistanhealthnews.com/article/915421058-sharps-technology-becomes-skyai-inc-with-new-ticker-symbol-skya-establishing-category-defining-agentic-finance-platform-serving-global-south Turkmenistan Health News en PressRelease 2026-05-27T11:00:00+00:00 Sharps Technology Becomes SkyAI, Inc. with New Ticker Symbol “SKYA”; Establishing Category-defining Agentic Finance Platform Serving Global South https://ml.globenewswire.com/media/7e8b9bfa-42f5-446c-932a-41a01c25ed6b/small/sharps-technology-nasdaq-stss-white-background-png.png https://www.turkmenistanhealthnews.com/article/915421092-mediwound-reports-first-quarter-2026-financial-results-and-provides-corporate-update Turkmenistan Health News en PressRelease 2026-05-27T11:00:00+00:00 MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/55509183-b8b9-4da4-ae63-92c83760b5d9/small/mdwd-logo-jpg.jpg https://www.turkmenistanhealthnews.com/article/915421105-telix-to-participate-in-william-blair-growth-stock-and-jefferies-global-healthcare-conferences Turkmenistan Health News en PressRelease 2026-05-27T11:00:00+00:00 Telix to Participate in William Blair Growth Stock and Jefferies Global Healthcare Conferences https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png https://www.turkmenistanhealthnews.com/article/915420230-ani-pharmaceuticals-to-present-at-the-2026-jefferies-global-healthcare-conference Turkmenistan Health News en PressRelease 2026-05-27T10:50:00+00:00 ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference https://ml.globenewswire.com/media/24d1d851-9075-4d6e-b22c-0c23a5ef0b36/small/ani-logo-png.png https://www.turkmenistanhealthnews.com/article/915421223-world-s-first-class-iii-approval-for-a-breakthrough-medical-imaging-ai-diagens-ai-autovision Turkmenistan Health News en PressRelease 2026-05-27T10:49:09+00:00 World’s First Class III Approval for a Breakthrough Medical Imaging AI: Diagens AI AutoVision® https://ml.globenewswire.com/media/97921037-563c-4fca-95a3-bbcc69b4d2b1/medium/hangzhou-diagens-biotechnology.jpg https://www.turkmenistanhealthnews.com/article/915420863-apogee-therapeutics-announces-1-3-billion-strategic-financing-collaboration-with-blackstone-life-sciences-to-advance-phase-3-development-and Turkmenistan Health News en PressRelease 2026-05-27T10:31:00+00:00 Apogee Therapeutics Announces $1.3 Billion Strategic Financing Collaboration with Blackstone Life Sciences to Advance Phase 3 Development and Commercialization of Zumilokibart https://ml.globenewswire.com/media/c7ab4c17-2e41-4560-b2a2-70d0c23c8c8b/small/apogeelogo-png.png